Abstract BACKGROUND The ThinPrep® Pap Test™(TP), a liquid‐based cervical cytology
preparation, was approved for use in the US in 1996. The purpose of this study was to …

Objective To compare the cytologic diagnoses and specimen adequacy of the ThinPrep Pap
Test with historical data within a distinct patient population to assess test performance and …

Abstract BACKGROUND The ThinPrep® Papanicolaou (Pap) test, a liquid‐based alternative
to the long‐used conventional Pap smear, received Food and Drug Administration approval …

OBJECTIVE: To compare the sensitivity, specificity and specimen adequacy of the ThinPrep
Pap Test (TP) with the conventional Pap Test (CV) in a low-risk population with subsequent …

Objective: To compare the frequency of Pap test results in a prospective series of direct to
vial ThinPrep tests to a cohort of conventionally prepared tests. To follow‐up all test results …

Study design Clinical trials of the ThinPrep Beta and the ThinPrep 2000 performed in the
United States were reviewed. In each a single sample was used to first prepare a …

The conventional Papanicolaou smear is associated with variable false positive and false
negative rates, difficulties with interpretation and high unsatisfactory and suboptimal rates …

BACKGROUND This study compared the findings of cervical cytology screening by
ThinPrep Papanicoloau (Pap) tests (TP) with the findings of screening by conventional …

Abstract The false-negative Papanicolaou (Pap) smear is the major quality issue currently
facing the practitioners of diagnostic cytology. Failure to detect cervical disease in women …

The performance of the ThinPrep® Pap Test™(TP)(Cytyc Corp., Boxborough, MA) for
detection of cervical cancer precursors in a population with a low incidence of disease was …